SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001753926-24-000330
Filing Date
2024-02-15
Accepted
2024-02-15 20:36:00
Documents
2
Period of Report
2024-02-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4092
2 POWER OF ATTORNEY g084040_ex24.htm EX-24 10029
  Complete submission text file 0001753926-24-000330.txt   15729
Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Chromocell Therapeutics Corp (Issuer) CIK: 0001919246 (see all company filings)

IRS No.: 863335449 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 25 AND 28 NORTH WALL QUAY DUBLIN L2 D01 H104
Business Address 25 AND 28 NORTH WALL QUAY DUBLIN L2 D01 H104 (203) 400-8579
Motif Pharmaceuticals Ltd. (Reporting) CIK: 0001988875 (see all company filings)

State of Incorp.: L2 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41964 | Film No.: 24645541